Skip to main content
Signal8

Stemtech Corp (STEK)

Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.

Sector: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Industry: Drug Manufacturers - Specialty & Generic

Stemtech Corporation logo

Stemtech Corporation

OTC:STEKHealthcare
$0.0001
Mkt Cap$300K
EV-
Float2.7B
O/S3B
VOL1.5M sh
$ Vol$150
RVOL0.13×
Inst Own-
Net Cash/Sh-
Dilution

Stemtech Corp (STEK) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 5 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
1 warrant series recorded as outstanding
Most recent offering
None recorded in the filings reviewed

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro